|
1
|
Dalen JE, Alpert JS, Goldberg RJ and
Weinstein RS: The epidemic of the 20(th) century: Coronary heart
disease. Am J Med. 127:807–812. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Aggarwal B and Menon V: Recent advances in
treatment of acute coronary syndromes. F1000Prime Rep. 5:562013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Alexander W: American academy of
dermatology and american college of cardiology. P T. 39:370–374.
2014.PubMed/NCBI
|
|
4
|
Levitsky S: Protecting the myocardial cell
during coronary revascularization. The William W. L. Glenn lecture.
Circulation. 114 (Suppl 1):I339–I343. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fang Y and Hu J: Toll-like receptor and
its roles in myocardial ischemic/reperfusion injury. Med Sci Monit.
17:RA100–RA109. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Akira S, Uematsu S and Takeuchi O:
Pathogen recognition and innate immunity. Cell. 124:783–801. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Luo M, Yan D, Sun Q, Tao J, Xu L, Sun H
and Zhao H: Ginsenoside Rg1 attenuates cardiomyocyte apoptosis and
inflammation via the TLR4/NF-kB/NLRP3 pathway. J Cell Biochem. Nov
11–2019.(Epub ahead of print).
|
|
8
|
Akbarshahi H, Axelsson JB, Said K,
Malmström A, Fischer H and Andersson R: TLR4 dependent heparan
sulphate-induced pancreatic inflammatory response is IRF3-mediated.
J Transl Med. 9:2192011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen PG, Guan YJ, Zha GM, Jiao XQ, Zhu HS,
Zhang CY, Wang YY and Li HP: Swine IRF3/IRF7 attenuates
inflammatory responses through TLR4 signaling pathway. Oncotarget.
8:61958–61968. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y, Chen L, Tian Z, Shen X, Wang X, Wu
H, Zou J and Liang J: CRISPR-Cas9 mediated gene knockout in human
coronary artery endothelial cells reveals a pro-inflammatory role
of TLR2. Cell Biol Int. 42:187–193. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ohto U, Miyake K and Shimizu T: Crystal
structures of mouse and human RP105/MD-1 complexes reveal unique
dimer organization of the toll-like receptor family. J Mol Biol.
413:815–825. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Miyake K, Yamashita Y, Hitoshi Y, Takatsu
K and Kimoto M: Murine B cell proliferation and protection from
apoptosis with an antibody against a 105-kD molecule:
Unresponsiveness of X-linked immunodeficient B cells. J Exp Med.
180:1217–1224. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Selimovic D, Hassan M, Haikel Y and Hengge
UR: Taxol-induced mitochondrial stress in melanoma cells is
mediated by activation of c-Jun N-terminal kinase (JNK) and p38
pathways via uncoupling protein 2. Cell Signal. 20:311–322. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Karper JC, Ewing MM, de Vries MR, de Jager
SC, Peters EA, de Boer HC, van Zonneveld AJ, Kuiper J, Huizinga EG,
Brondijk TH, et al: TLR accessory molecule RP105 (CD180) is
involved in post-interventional vascular remodeling and soluble
RP105 modulates neointima formation. PLoS One. 8:e679232013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wezel A, van der Velden D, Maassen JM,
Lagraauw HM, de Vries MR, Karper JC, Kuiper J, Bot I and Quax PH:
RP105 deficiency attenuates early atherosclerosis via decreased
monocyte influx in a CCR2 dependent manner. Atherosclerosis.
238:132–139. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang H, Wang H, Ju Z, Ragab AA, Lundbäck
P, Long W, Valdes-Ferrer SI, He M, Pribis JP, Li J, et al: MD-2 is
required for disulfide HMGB1-dependent TLR4 signaling. J Exp Med.
212:5–14. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li X, Yang J, Yang J, Dong W, Li S, Wu H
and Li L: RP105 protects against myocardial ischemia-reperfusion
injury via suppressing TLR4 signaling pathways in rat model. Exp
Mol Pathol. 100:281–286. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang J, Yang C, Yang J, Ding J, Li X, Yu
Q, Guo X, Fan Z and Wang H: RP105 alleviates myocardial ischemia
reperfusion injury via inhibiting TLR4/TRIF signaling pathways. Int
J Mol Med. 41:3287–3295. 2018.PubMed/NCBI
|
|
19
|
Liu QS, Cheng ZW, Xiong JG, Cheng S, He XF
and Li XC: Erythropoietin pretreatment exerts anti-inflammatory
effects in hepatic ischemia/reperfusion-injured rats via
suppression of the TLR2/NF-kappaB pathway. Transplant Proc.
47:283–289. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pope MR and Fleming SD: TLR2 modulates
antibodies required for intestinal ischemia/reperfusion-induced
damage and inflammation. J Immunol. 194:1190–1198. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ulbrich F, Lerach T, Biermann J, Kaufmann
KB, Lagreze WA, Buerkle H, Loop T and Goebel U: Argon mediates
protection by interleukin-8 suppression via a
TLR2/TLR4/STAT3/NF-kappaB pathway in a model of apoptosis in
neuroblastoma cells in vitro and following ischemia-reperfusion
injury in rat retina in vivo. J Neurochem. 138:859–873. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang J, Chen L, Yang J, Ding J, Li S, Wu
H, Zhang J, Fan Z, Dong W and Li X: MicroRNA-22 targeting CBP
protects against myocardial ischemia-reperfusion injury through
anti-apoptosis in rats. Mol Biol Rep. 41:555–561. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang HB and Yang J, Ding JW, Chen LH, Li
S, Liu XW, Yang CJ, Fan ZX and Yang J: RNAi-mediated
down-regulation of CD47 protects against
ischemia/reperfusion-induced myocardial damage via activation of
eNOS in a rat model. Cell Physiol Biochem. 40:1163–1174. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang B, Zhong S, Zheng F, Zhang Y, Gao F,
Chen Y, Lu B, Xu H and Shi G: N-n-butyl haloperidol iodide protects
cardiomyocytes against hypoxia/reoxygenation injury by inhibiting
autophagy. Oncotarget. 6:24709–24721. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang X, Du Q, Yang Y, Wang J, Dou S, Liu
C and Duan J: The protective effect of Luteolin on myocardial
ischemia/reperfusion (I/R) injury through TLR4/NF-kappaB/NLRP3
inflammasome pathway. Biomed Pharmacother. 91:1042–1052. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu NB, Wu M, Chen C, Fujino M, Huang JS,
Zhu P and Li XK: Novel molecular targets participating in
myocardial ischemia-reperfusion injury and cardioprotection.
Cardiol Res Pract. 2019:69351472019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Davidson SM, Ferdinandy P, Andreadou I,
Bøtker HE, Heusch G, Ibáñez B, Ovize M, Schulz R, Yellon DM,
Hausenloy DJ, et al: Multitarget strategies to reduce myocardial
ischemia/reperfusion injury: JACC review topic of the week. J Am
Coll Cardiol. 73:89–99. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Quiat D and Olson EN: MicroRNAs in
cardiovascular disease: From pathogenesis to prevention and
treatment. J Clin Invest. 123:11–18. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang JX, Zhang XJ, Li Q, Wang K, Wang Y,
Jiao JQ, Feng C, Teng S, Zhou LY, Gong Y, et al: MicroRNA-103/107
regulate programmed necrosis and myocardial ischemia/reperfusion
injury through targeting FADD. Circ Res. 117:352–363. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang CJ, Yang J, Yang J and Fan ZX:
Radioprotective 105kDa protein (RP105): Is a critical therapeutic
target for alleviating ischemia reperfusion induced myocardial
damage via TLR4 signaling pathway. Int J Cardiol. 222:1069–1070.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Eltzschig HK and Eckle T: Ischemia and
reperfusion-from mechanism to translation. Nat Med. 17:1391–1401.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Joshi S, Wei J and Bishopric NH: A cardiac
myocyte-restricted Lin28/let-7 regulatory axis promotes
hypoxia-mediated apoptosis by inducing the AKT signaling suppressor
PIK3IP1. Biochim Biophys Acta. 1862:240–251. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sun Y, Ye L, Jiang C, Jiang J, Hong H and
Qiu L: Over-expression of HSPA12B protects mice against myocardium
ischemic/reperfusion injury through a PPARgamma-dependent
PI3K/Akt/eNOS pathway. Am J Transl Res. 7:2724–2737.
2015.PubMed/NCBI
|
|
35
|
Huh HD, Ra EA, Lee TA, Kang S, Park A, Lee
E, Choi JL, Jang E, Lee JE, Lee S and Park B: STRAP acts as a
scaffolding protein in controlling the TLR2/4 signaling pathway.
Sci Rep. 6:388492016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Takeda K and Akira S: TLR signaling
pathways. Semin Immunol. 16:3–9. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dunne A, Carpenter S, Brikos C, Gray P,
Strelow A, Wesche H, Morrice N and O'Neill LA: IRAK1 and IRAK4
promote phosphorylation, ubiquitination, and degradation of MyD88
adaptor-like (Mal). J Biol Chem. 291:248022016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Guo X, Jiang H, Yang J, Chen J, Yang J,
Ding JW, Li S, Wu H and Ding HS: Radioprotective 105 kDa protein
attenuates ischemia/reperfusion-induced myocardial apoptosis and
autophagy by inhibiting the activation of the TLR4/NF-kappaB
signaling pathway in rats. Int J Mol Med. 38:885–893. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang J, Guo X, Yang J, Ding JW, Li S, Yang
R, Fan ZX and Yang CJ: RP105 protects against apoptosis in
ischemia/reperfusion-induced myocardial damage in rats by
suppressing TLR4-mediated signaling pathways. Cell Physiol Biochem.
36:2137–2148. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nagai Y, Akashi S, Nagafuku M, Ogata M,
Iwakura Y, Akira S, Kitamura T, Kosugi A, Kimoto M and Miyake K:
Essential role of MD-2 in LPS responsiveness and TLR4 distribution.
Nat Immunol. 3:667–672. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
41
|
Brandl K, Glück T, Hartmann P, Salzberger
B and Falk W.: A designed TLR4/MD-2 complex to capture LPS. J
Endotoxin Res. 11:197–206. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Roh E, Lee HS, Kwak JA, Hong JT, Nam SY,
Jung SH, Lee JY, Kim ND, Han SB and Kim Y: MD-2 as the target of
nonlipid chalcone in the inhibition of endotoxin LPS-induced TLR4
activity. J Infect Dis. 203:1012–1020. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lee SM, Hutchinson M and Saint DA: The
role of Toll-like receptor 4 (TLR4) in cardiac
ischaemic-reperfusion injury, cardioprotection and preconditioning.
Clin Exp Pharmacol Physiol. 43:864–871. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Piao W, Ru LW, Piepenbrink KH, Sundberg
EJ, Vogel SN and Toshchakov VY: Recruitment of TLR adapter TRIF to
TLR4 signaling complex is mediated by the second helical region of
TRIF TIR domain. Proc Natl Acad Sci USA. 110:19036–19041. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ayme-Dietrich E, Aubertin-Kirch G,
Maroteaux L and Monassier L: Cardiovascular remodeling and the
peripheral serotonergic system. Arch Cardiovasc Dis. 110:51–59.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ayme-Dietrich E, Marzak H, Lawson R, Mokni
W, Wendling O, Combe R, Becker J, El Fertak L, Champy MF, Matz R,
et al: Contribution of serotonin to cardiac remodeling associated
with hypertensive diastolic ventricular dysfunction in rats. J
Hypertens. 33:2310–2321. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lei Y, Yang G, Hu L, Piao L, Inoue A,
Jiang H, Sasaki T, Zhao G, Yisireyili M, Yu C, et al: Increased
dipeptidyl peptidase-4 accelerates diet-related vascular aging and
atherosclerosis in ApoE-deficient mice under chronic stress. Int J
Cardiol. 243:413–420. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yang G, Lei Y, Inoue A, Piao L, Hu L,
Jiang H, Sasaki T, Wu H, Xu W, Yu C, et al: Exenatide mitigated
diet-induced vascular aging and atherosclerotic plaque growth in
ApoE-deficient mice under chronic stress. Atherosclerosis.
264:1–10. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Cheng XW, Huang Z, Kuzuya M, Okumura K and
Murohara T: Cysteine protease cathepsins in atherosclerosis-based
vascular disease and its complications. Hypertension. 58:978–986.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Cheng XW, Shi GP, Kuzuya M, Sasaki T,
Okumura K and Murohara T: Role for cysteine protease cathepsins in
heart disease: Focus on biology and mechanisms with clinical
implication. Circulation. 125:1551–1562. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Selmi C: Autoimmunity in 2016. Clin Rev
Allergy Immunol. 53:126–139. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ha T, Hu Y, Liu L, Lu C, McMullen JR,
Kelley J, Kao RL, Williams DL, Gao X and Li C: TLR2 ligands induce
cardioprotection against ischaemia/reperfusion injury through a
PI3K/Akt-dependent mechanism. Cardiovasc Res. 87:694–703. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Liu B, Zhang N, Liu Z, Fu Y, Feng S, Wang
S, Cao Y, Li D, Liang D, Li F, et al: RP105 involved in activation
of mouse macrophages via TLR2 and TLR4 signaling. Mol Cell Biochem.
378:183–193. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Liu B, Fu Y, Feng S, Zhang X, Liu Z, Cao
Y, Li D, Liang D, Li F, Zhang N and Yang Z: Involvement of RP105
and toll-like receptors in the activation of mouse peritoneal
macrophages by Staphylococcus aureus. Scand J Immunol. 78:8–16.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Blumenthal A, Kobayashi T, Pierini LM,
Banaei N, Ernst JD, Miyake K and Ehrt S: RP105 facilitates
macrophage activation by Mycobacterium tuberculosis lipoproteins.
Cell Host Microbe. 5:35–46. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Frazao JB, Errante PR and Condino-Neto A:
Toll-like receptors' pathway disturbances are associated with
increased susceptibility to infections in humans. Arch Immunol Ther
Exp (Warsz). 61:427–443. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Mersmann J, Habeck K, Latsch K, Zimmermann
R, Jacoby C, Fischer JW, Hartmann C, Schrader J, Kirschning CJ and
Zacharowski K: Left ventricular dilation in toll-like receptor 2
deficient mice after myocardial ischemia/reperfusion through
defective scar formation. Basic Res Cardiol. 106:89–98. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Lepper PM and Bals R: On the edge:
Targeting Toll-like receptor 2 in ischemia/reperfusion injury. Circ
Cardiovasc Interv. 5:146–149. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Divanovic S, Trompette A, Petiniot LK,
Allen JL, Flick LM, Belkaid Y, Madan R, Haky JJ and Karp CL:
Regulation of TLR4 signaling and the host interface with pathogens
and danger: The role of RP105. J Leukoc Biol. 82:265–271. 2007.
View Article : Google Scholar : PubMed/NCBI
|
